VIMECON GmbH – one of the most innovative medical technology companies in the world
VIMECON researches new techniques and components for simplifying diagnosis and treatment methods in cardiovascular medicine. Our top-priority goal is the treatment of diseases while limiting complications during diagnostic and therapeutic interventions with improved quality of life and prolonged life-span.
Furthermore VIMECON aims at lowering the costs of healthcare by developing standardized treatment methods for:
- Cardiac arrhythmia
- High blood pressure
- Heart valve defects
- Artery and venous diseases
- Cardiac insufficiency (heart failure)
- Cardiomuscular diseases
- Congenital and acquired heart failures
For this purpose VIMECON has focused competencies in a unique network of experts. Long-term cooperation agreements allow us to quickly gain access to relevant up-to-date data from all kinds of fields of scientific knowledge.
VIMECON specializes in the development of individual micro catheter systems for use in research and medicine, in particular for genetic engineering as well as stem cell research and therapy. VIMECON uses proprietary high-performance-materials and technologies in order to offer you a micro catheter system of premium quality and best performance with diameters starting from 0.3 French.
VIMECON also offers a comprehensive range of dosing, feed and measuring systems, which are tailored to the specific requirements of your laboratory work. If you require individual product solutions please send us your enquiry stating your specifications. We will get back to you with our proposals very shortly.